EP 3089729 A4 20170614 - ALLANTOIN COMPOSITIONS FOR TREATING INFLAMMATORY SKIN CONDITIONS
Title (en)
ALLANTOIN COMPOSITIONS FOR TREATING INFLAMMATORY SKIN CONDITIONS
Title (de)
ALLANTOINZUSAMMENSETZUNGEN ZUR BEHANDLUNG ENTZÜNDLICHER HAUTERKRANKUNGEN
Title (fr)
COMPOSITIONS D'ALLANTOÏNE POUR TRAITER DES AFFECTIONS CUTANÉES INFLAMMATOIRES
Publication
Application
Priority
US 2014010248 W 20140103
Abstract (en)
[origin: WO2015102642A1] Embodiments herein provide formulations and methods for treatment of inflammatory skin diseases using allantoin in an amount from about 0.5% to about 15.0% by weight. Inflammatory skin diseases treated by embodiments herein include, without limitation, cutaneous porphyria, sclerodema, epidermolysis bulosa, psoriasis, decubitus ulcers, pressure ulcers, diabetic ulcers, venous stasis ulcers, sickle cell ulcers, ulcers caused by burns, eczema, urticaria, atopic dermatitis, dermatitis herpetiform, contact dermatitis, arthritis, gout, lupus erythematosus, acne, alopecia, carcinomas, psoriasis, rosacea, miliaria, skin infections, post-operative care of incisions, post-operative skin care following any variety of plastic surgery operations, skin care following radiation treatment, care of dry, cracked or aged skin and skin lines as well as other conditions affecting the skin and having an inflammatory component, symptoms thereof, or a combination thereof. Symptoms treated may include pain, inflammation, redness, itching, scarring, skin thickening, milia, or a combination thereof.
IPC 8 full level
A61K 8/06 (2006.01); A61K 8/49 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 47/06 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01)
CPC (source: EP)
A61K 8/062 (2013.01); A61K 8/4946 (2013.01); A61K 9/0014 (2013.01); A61K 9/107 (2013.01); A61P 17/00 (2017.12); A61P 17/02 (2017.12); A61P 17/04 (2017.12); A61P 17/06 (2017.12); A61P 17/16 (2017.12); A61P 25/02 (2017.12); A61P 29/00 (2017.12); A61Q 19/00 (2013.01); A61Q 19/08 (2013.01)
Citation (search report)
- [XI] US 2006134149 A1 20060622 - FARBER ELLIOTT [US]
- [E] WO 2015100348 A1 20150702 - SCIODERM INC [US]
- [A] EP 1579861 A2 20050928 - WOLF WILHELM R [DE]
- See references of WO 2015102642A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2015102642 A1 20150709; AU 2014374416 A1 20160721; BR 112016015641 A2 20171003; BR 112016015641 A8 20171010; CA 2935836 A1 20150709; EP 3089729 A1 20161109; EP 3089729 A4 20170614; JP 2017502053 A 20170119; MX 2016008795 A 20170323
DOCDB simple family (application)
US 2014010248 W 20140103; AU 2014374416 A 20140103; BR 112016015641 A 20140103; CA 2935836 A 20140103; EP 14876324 A 20140103; JP 2016544415 A 20140103; MX 2016008795 A 20140103